Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSCs for newly diagnosed type 1 diabetes
NCT01157403Phase 3Unknown
- Start
- Jul 2010
- Primary completion
- Jul 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous bone marrow derived mesenchymal stromal cells in type 1 diabetes mellitus (T1D). Status: unknown.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01157403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01157403.